In summary, this study provides a new understanding of the inhibitory effect and cytotoxic mechanism of USP1 inhibitors on HCC cell proliferation, suggesting that targeting USP1 may be a potential therapeutic strategy for HCC. This evidence concerns the gene USP1 and hepatocellular carcinoma.